52-Week Performance Chart

Powered by FactSet Research Systems Inc

Corporate Actions/Books Closed

More
Aug 28, 2024
Novonesis (Novozymes) B - Books Closed / Open for Issuance
Mar 21, 2024
Novonesis (Novozymes) B - Books Re-opened for Issuance
Mar 12, 2024
Novozymes A/S - Name Change to - Novonesis (Novozymes) B
Mar 07, 2024
Novozymes A/S - Books Closed for Issuance

No DR Events are available.

Data provided by Thomson Reuters

Recent Dividends & Distributions

More
US RECORD DATE US PAYABLE DATE NET DR AMOUNT
Apr 07, 2025 Apr 23, 2025 0.3779
Sep 09, 2024 Sep 18, 2024 0.1653
May 02, 2024 May 20, 2024 0.1852
Oct 23, 2023 Nov 01, 2023 0.3835

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
OKOWORLD LUX SA 145,000
HSBC Global Asset Management (France) SA 105,517
OP Asset Management Ltd. 42,755
TOP MUTUAL FUND HOLDERS POSITION
OekoWorld FCP - Klima 130,000
HSBC GIF - Global Equity Circular Economy 105,517
OP-Europe Index Fund 42,755

Data provided by FactSet Research Systems Inc.

Important Notice to Investors of Unsponsored DRs and GDNs:

From time to time, BNY may pay a rebate to brokers that deposit shares with BNY for the issuance of unsponsored depositary receipts (DRs) or global depositary notes. BNY assumes no obligation or responsibility, and expressly disclaims any liability arising out of, or relating to, such rebates, including without limitation whether the rebate or any portion of it is passed on to the beneficial holders by the brokers.
Unsponsored DRs may be issued by multiple depositary banks servicing a particular DR program. Consequently, as a result of Depository Trust & Clearing Corporation (“DTCC”) practice, the actual cash distribution fees charged may differ from the BNY fees detailed in the fee schedule as fees will be charged in accordance with the fee schedule of the depositary bank that is considered to be the “First Filer”. The fees to be charged for any particular unsponsored cash distribution will be disclosed on the event announcement published by the “First Filer”. BNY takes no responsibility for the level of fees charged by any other depositary bank. The “First Filer” is the depositary bank that filed the first Form F-6 for a program with the U.S. Securities and Exchange Commission (“SEC”). In the event the actual “First Filer” does not have DRs outstanding for a program, the next depositary bank who filed a
Form F-6 with the SEC and has DRs outstanding will be deemed to be the First Filer for these purposes.

DR Details

DR Symbol NVZMY
CUSIP 670108109
DR Venue OTC
DR ISIN US6701081092
Ratio DR:ORD 1:1
First Filer BK
Underlying ISIN DK0060336014
Underlying SEDOL B798FW0
Country Denmark
Effective Date Dec 23, 2002
Depositary BK, CIT, DB, JPMC (Unsponsored)
Industry Pharma. & Biotech.
Novozymes is engaged in the production and sale of industrial enzymes and microorganisms for industries. The Company operates in two divisions: Consumer Biosolutions and Agriculture & Industrial Biosolutions. Consumer Biosolutions is engaged in the production and distribution of biosolutions for household care, baking, beverages, food, proteins and human health. The Agriculture & Industrial Biosolutions is engaged in the production of enzymes and solutions for bioenergy, grain and tech processing, agriculture and animal health.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.1000
Cancellation up to $0.1000
Cash Distribution up to $0.1000
Issuance up to $0.1000
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.1000
Rights - Issuance up to $0.1000
Stock Dividend up to $0.1000
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 64.91 1,304,777 62,132
Mar.25 58.41 311,543 14,835
Feb.25 60.27 402,091 21,163

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE